Literature DB >> 11429707

Contrasting roles of NF-kappaB and JNK in arsenite-induced p53-independent expression of GADD45alpha.

F Chen1, Z Zhang, S S Leonard, X Shi.   

Abstract

Growth arrest and DNA damage-inducible protein 45alpha (GADD45alpha) is an important cell cycle checkpoint protein that arrests cells at G2/M phase by inhibiting the activity of G2-specific kinase, cyclin B/p34cdc2. We report here that arsenite induces GADD45alpha expression in a p53-independent fashion and that this GADD45alpha induction by arsenite is regulated by NF-kappaB and c-Jun-N-terminal kinase (JNK) oppositely. In human bronchial epithelial cells overexpressing a kinase-mutated form of IkappaB kinase beta (IKKbeta-KM), the activation of NF-kappaB was inhibited. However, the G2/M cell cycle arrest and expression of GADD45alpha was substantially enhanced in response to arsenite in these cells. Expression of a dominant-negative mutant of SEK1 that blocks JNK activation decreased arsenite-induced GADD45alpha expression. Analysis of GADD45alpha expression in both wild-type and p53-/- fibroblasts indicated that the induction of GADD45alpha by arsenite was independent of the status of p53 protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429707     DOI: 10.1038/sj.onc.1204442

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Gadd45 proteins: relevance to aging, longevity and age-related pathologies.

Authors:  Alexey A Moskalev; Zeljka Smit-McBride; Mikhail V Shaposhnikov; Ekaterina N Plyusnina; Alex Zhavoronkov; Arie Budovsky; Robi Tacutu; Vadim E Fraifeld
Journal:  Ageing Res Rev       Date:  2011-10-05       Impact factor: 10.895

2.  Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway.

Authors:  Fei Chen; Zhuo Zhang; Jacquelyn Bower; Yongju Lu; Stephen S Leonard; Min Ding; Vince Castranova; Helen Piwnica-Worms; Xianglin Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

Review 3.  MAPK signaling pathway-targeted marine compounds in cancer therapy.

Authors:  Jiaen Wei; Ruining Liu; Xiyun Hu; Tingen Liang; Zhiran Zhou; Zunnan Huang
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-03       Impact factor: 4.553

4.  Deficiency in Ikkbeta gene enhances arsenic-induced gadd45alpha expression.

Authors:  Yadong Zhang; Yongju Lu; Min Ding; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

Review 5.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

6.  Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line.

Authors:  Woo-Sik Jeong; In-Wha Kim; Rong Hu; Ah-Ng Tony Kong
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 7.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

8.  c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.

Authors:  Hong Seok Choi; Ann M Bode; Jung-Hyun Shim; Sung-Young Lee; Zigang Dong
Journal:  Mol Cell Biol       Date:  2009-02-09       Impact factor: 4.272

9.  Nucleolin links to arsenic-induced stabilization of GADD45alpha mRNA.

Authors:  Yadong Zhang; Deepak Bhatia; Hongfeng Xia; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Nucleic Acids Res       Date:  2006-01-18       Impact factor: 16.971

10.  p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K-Akt pathways.

Authors:  Du Cheng; Lei Zhao; Leiliang Zhang; Yongfang Jiang; Yi Tian; Xinqiang Xiao; Guozhong Gong
Journal:  J Gen Virol       Date:  2012-10-31       Impact factor: 3.891

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.